Structure-guided residence time optimization of a dabigatran reversal agent.
Schiele, F., van Ryn, J., Litzenburger, T., Ritter, M., Seeliger, D., Nar, H.(2015) Mabs 7: 871-880
- PubMed: 26047352 
- DOI: 10.1080/19420862.2015.1057364
- Primary Citation of Related Structures:  
- PubMed Abstract: 
Novel oral anticoagulants are effective and safe alternatives to vitamin-K antagonists for anticoagulation therapy. However, anticoagulation therapy in general is associated with an elevated risk of bleeding. Idarucizumab is a reversal agent for the ...